A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies
Burris, 3rd, Howard A, Taylor, Charles W, Jones, Suzanne F, Koch, Kevin M, Versola, Melissa J, Arya, Niki, Fleming, Ronald A, Smith, Deborah A, Pandite, Lini, Spector, Neil, Wilding, George
Published in Clinical cancer research (01.11.2009)
Published in Clinical cancer research (01.11.2009)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies
CHU, Quincy S. C, SCHWARTZ, Garry, HO, Peter T. C, ROWINSKY, Eric K, DE BONO, Johann, SMITH, Deborah A, KOCH, Kevin M, VERSOLA, Melissa J, PANDITE, Lini, ARYA, Nikita, CURTRIGHT, Jan, FLEMING, Ronald A
Published in Journal of clinical oncology (20.08.2007)
Published in Journal of clinical oncology (20.08.2007)
Get full text
Journal Article
Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV)
Midgley, R., Flaherty, K. T., Haller, D. G., Versola, M. J., Smith, D. A., Koch, K. M., Pandite, L., Kerr, D. J., O’Dwyer, P. J., Middleton, M. R.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors
Schwartz, G., Chu, Q. S.-C., Hammond, L. A., Mita, M., Curtright, J., Versola, M. J., Koch, K., Pandite, L. N., Ho, P. T. C., Rowinsky, E. K.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors
Pandite, L., Burris, H. A., Jones, S., Wilding, G., Taylor, C., Versola, M. J., Smith, D. A., Stead, A., Koch, K. M., Spector, N. L.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors
Schwartz, G., Chu, Q. S.-C., Hammond, L. A., Mita, M., Curtright, J., Versola, M. J., Koch, K., Pandite, L. N., Ho, P. T. C., Rowinsky, E. K.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors
Pandite, L., Burris, H. A., Jones, S., Wilding, G., Taylor, C., Versola, M. J., Smith, D. A., Stead, A., Koch, K. M., Spector, N. L.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009)
Jones, S. F., Hainsworth, J. D., Spigel, D. R., Peacock, N. W., Willcutt, N. T., Pandite, L. N., Versola, M. J., Koch, K. M., Greco, F., Burris, H. A.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009)
Jones, S. F., Hainsworth, J. D., Spigel, D. R., Peacock, N. W., Willcutt, N. T., Pandite, L. N., Versola, M. J., Koch, K. M., Greco, F., Burris, H. A.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article